Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260572 · ClinicalTrials.gov registry record
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
A clinical trial of Gastroesophageal Reflux Disease, sponsored by University of Pittsburgh.
- Active
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT00260572 is a study of Gastroesophageal Reflux Disease that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 2,500 participants, above the 243-participant average among 24 other Gastroesophageal Reflux Disease trials with a reported enrollment target (929% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00260572, a study of Gastroesophageal Reflux Disease, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The aims of this study are to create a prospective data base to evaluate the long term outcomes of medical and surgical treatment of gastroesophageal reflux disease (GERD); to measure standard outcomes as well as patient derived outcomes such as general and disease specific quality of life (QOL) issues and patient satisfaction; to refine the parameters that may identify patients who will benefit from surgery for GERD; and to identify possible determinants of failure of both medical and surgical treatments of reflux.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires to evaluate QOL
- BEHAVIORAL Questionnaires to evaluate heartburn and quality of life
- BEHAVIORAL Questionnaire to evaluate satisfaction with treatment
- BEHAVIORAL Questionnaire to evaluate presence or absence of pain
Study Locations (1)
Pennsylvania
- UPMC Department of Cardiothoracic Surgery - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 1999-04 |
| Est. Completion | 2050-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00260572
The ClinicalTrials.gov registry entry for NCT00260572 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 243-participant average among 24 other Gastroesophageal Reflux Disease trials with a reported enrollment target (929% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastroesophageal Reflux Disease appearing as the primary indexed condition, and to 4 interventions - of which Questionnaires to evaluate QOL is the first listed.
NCT00260572 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00260572 about?
NCT00260572 is a clinical study titled "Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease". The aims of this study are to create a prospective data base to evaluate the long term outcomes of medical and surgical treatment of gastroesophageal reflux disease (GERD); to measure standard outcomes as well as patient derived outcomes such as general and disease specific quality of life (QOL) iss...
What is the current status of trial NCT00260572?
This trial is currently active not recruiting. The enrollment target is 2,500 participants. The study started on 1999-04. Estimated completion is 2050-12.
What conditions does trial NCT00260572 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux Disease.
What interventions are being tested in trial NCT00260572?
The interventions under investigation include: Questionnaires to evaluate QOL (BEHAVIORAL), Questionnaires to evaluate heartburn and quality of life (BEHAVIORAL), Questionnaire to evaluate satisfaction with treatment (BEHAVIORAL), Questionnaire to evaluate presence or absence of pain (BEHAVIORAL).
Who is sponsoring clinical trial NCT00260572?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00260572 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
GCC Agonist Signal in the Small Intestine
ACTIVE NOT RECRUITING · Phase 1
-
Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients
ACTIVE NOT RECRUITING
-
Morphological Markers of Gastroesophageal Reflux Disease (GERD)
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.